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Abstract The production of halocins, bacteriocin-like
proteins of ecological signiﬁcance, is a frequent charac-
teristic of species from the family Halobacteriaceae.
Halocin H1, produced by Haloferax mediterranei strain
M2a, is a single 31-kDa polypeptide. Its puriﬁcation was
achieved by combining two chromatographic systems:
Sepharose 4B linked to bacitracin followed by hy-
droxylapatite Bio-gel HTP. Halocin H1 required con-
centrations of NaCl higher than 1.5 M to maintain its
activity. Haoarchaeal strains showed a diﬀerential
degree of sensitivity to the action of this halocin.
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Introduction
The term bacteriocin is applied to a wide range of bio-
logically active proteins of bacterial origin that exhibit
antimicrobial properties against other bacterial species,
usually closely related to the producer organism [1]. The
production of these proteins has been reported in
microorganisms inhabiting a wide variety of ecosystems
such as soil [20], marine environments [4], or even the
gastrointestinal tract [1]. During the last decade, protein
antibiotics have been studied widely due to their
potential as preserving agents in the food industry,
controlling agents for infectious bacteria, etc. [3].
These antimicrobial proteins have been described not
only in Bacteria but also among Euryarchaeota (extreme
halophiles) or Crenarchaeota (hyperthermophiles)
[14, 17]. Haloarchaea are the dominant heterotrophic
population in hypersaline environments with salt con-
centrations exceeding 250–300 g l–1 [12]. The production
of antimicrobial proteins, named halocins, is a widely
distributed feature among haloarchaea [10 ,23]. Four
halocins, produced by diﬀerent species have been stud-
ied [8, 15, 16, 21]. Of these, three have been characterized
fully [2, 8, 15, 21] and were found to demonstrate great
heterogeneity in size, salt dependence, and spectrum of
activity. The mechanism of action of the halocins char-
acterized thus far seems to be related to changes in the
bioenergetic steady-state across the membrane [9, 22]; in
one case (halocin H6), the speciﬁc target has been
described [11].
The production of halocin H1 from Haloferax med-
iterranei M2a, previously known as H. mediterranei
Xia3, was initially described by Rodrı´guez-Valera et al.
[17]. This halocin was found to have a broad inhibitory
spectrum among diﬀerent haloarchaea. This work de-
scribes the puriﬁcation, characterization, and some
ecological features of halocin H1.
Materials and methods
Bacterial and Halobacteriaceae strains
Halocin H1 was obtained from the supernatant of H. mediterranei
M2a (former Xia3) culture as described by Platas et al. [13]. The
Haloarchaea used for the inhibitory tests were: Haloarcula hispa-
nica ATCC 33960, Haloarcula vallismortis ATCC 29715, Halo-
bacterium salinarum NRC 817, CCM 2090 and NRC 34002,
Halococcus morrhuae CCM 537, Haloferax gibbonsii ATCC 33959,
Haloferax volcanii NCMB 2012. Haloferax mediterranei ATCC
33500, M2b (Xia3b), M4 (Xia 10), M6 (Ma 2.31) and M10 (Gla
2.2) were kindly provided by the culture collection of the Depart-
ment of Produccio´n Vegetal y Microbiologı´a, Universidad Miguel
Herna´ndez, Elche, Spain.
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Media and growth conditions
All microorganisms were grown in media containing a mixture of
marine salts (referred to as SW), described by Rodrı´guez-Valera
et al. [17], in which the variable salt content is expressed as a per-
centage of its concentration [i.e. SW 25% has 25% (w/v) of salts in
the medium]. Halocin H1 was produced as reported in [13].
Haloarchaea were grown in SW 25% medium supplemented with
0.5% (w/v) yeast extract (Oxoid), pH 7, for liquid cultures and with
addition of 2% (w/v) agar for solid cultures.
Activity assays
Halocin activity was determined using Halobacterium salinarum
NRC 817 as the target strain [21]. The degree of inhibition was
measured as the inhibition zone diameter. Concentrated samples
were titrated to extinction, and activity was reported as arbitrary
units (AU) [21].
Salt dependence of halocin H1
The salt dependence of halocin H1 was studied by recursive con-
centration and replacement with SW solutions at diﬀerent ionic
concentrations, of 1-ml aliquots of a ﬁltered clariﬁed supernatant
of a culture (1,280 AU/ml) grown under the conditions reported in
[13]. These samples were assayed just after the ionic concentration
was changed, and again after 7 days of storage at 4 C. In a sep-
arate experiment, the original ionic concentration of the samples
was restored, using identical procedures, and assays were the car-
ried out to observe changes in the degree of inhibition. The samples
were concentrated and ﬁltered through a PLGC NMWL 10000
ultraﬁlter (Millipore) connected to a vacuum system.
Puriﬁcation of halocin H1
Two hundred milliliters of the clariﬁed supernatant of a culture of
H. mediterranei M2a grown under the conditions reported in [13]
were ﬁltered through a GVWP ﬁlter (13-mm diameter; 0.22 lm) to
remove the remaining cells. This supernatant was concentrated by
vacuum ultraﬁltration [PLGC NMWL 10000 CX-10 ultraﬁlter
(Millipore)] and dialyzed against 4.5 M NaCl, 50 mM Tris-HCl
(pH 8) buﬀer. The ﬁnal volume of the sample was 3.5 ml.
The ﬁrst puriﬁcation step was done using a 17·1.5-cm column
of CNBr-Sepharose 4B (Pharmacia) linked to bacitracin (Sigma),
as described by Stepanov and Rudenskaya [18,19], and equilibrated
with buﬀer 4.5 M NaCl, 50 mM Tris-HCl (pH 8). The elution was
carried out in the same buﬀer at a constant ﬂow rate of 0.4 ml/min,
and fractions (2 ml) were collected. Fractions showing the highest
antimicrobial activity were pooled (60 ml), concentrated by ultra-
ﬁltration until a ﬁnal volume of 3.5 ml was obtained, and dialyzed
against 2 M NaCl, 10 mM potassium phosphate buﬀer (pH 8).
The second puriﬁcation step was carried out in a 15·1-cm col-
umn of hydroxylapatite Bio-Gel HTP (Bio-Rad) equilibrated with
2 M NaCl, 10 mM potassium phosphate buﬀer (pH 8). The sample
was eluted in the same buﬀer at a ﬂow rate of 0.3 ml/min, and
fractions (2 ml) were collected. The fractions showing the highest
biological activity were pooled (40 ml), concentrated to 2 ml by
ultraﬁltration using the procedure described above, and stored at
4 C.
Protein concentration was measured using the Bradford meth-
od, and the degree of puriﬁcation of halocin was monitored by
SDS-PAGE, using a 12% acrylamide gel and applying a voltage of
80 V for 4 h in a TYR-NR-G41 minigel system (Biometra). Prior
to SDS-PAGE, the samples were concentrated and dialyzed against
distilled water to avoid the interference produced by high salt
concentrations in the electrophoresis. The halocin molecular mass
was determined using protein standards of known mass [low-
molecular-weight calibration kit (Pharmacia)].
Antimicrobial spectrum of halocin H1
Inhibition assays against haloarchaea were carried out in liquid
media. The subject microorganisms were seeded in the presence of
increasing concentrations of halocin (Table 3). The optical density
(OD) of the cultures at 620 nm was determined after 48 h of in-
cubation (late-exponential phase), and compared with the
OD620 nm of untreated control cultures The results were given as
percentage of inhibition determined by (OD620nm of control–
OD620nm of treated)/OD620nm of control.
Inhibition of growth among strains of H. mediterranei was de-
termined by a cross-sensitivity experiment: stationary cultures of the
diﬀerent strains were spread on agar plates, and 20 ll of a culture to
be tested was spotted on the agar surface. The inhibitory capacity
was determined by the observation of an antagonistic eﬀect.
Results
Salt dependence of the halocin activity
The environments in which haloarchaea live are hy-
persaline. The stability of an extracellular protein at
diﬀerent ionic strengths is a variable of ecological in-
terest, and critical for the design of a puriﬁcation strat-
egy. Halocins already characterized diﬀer in their ionic
stability: R1, H6, Ha1 and S8 are salt-independent [15,
16, 21], whereas H4 lost its antimicrobial activity when it
was dialyzed below 15% SW [17].
In order to evaluate the salt dependence of halocin
H1, aliquots of the supernatant were dialyzed against
buﬀers at various salt concentrations (Table 1). The
Table 1. Titration of the
antimicrobial activity of
1,280 AU/ml of halocin H1 af-
ter its dialysis against diﬀerent
saline concentrations
Dialysis conditions Titration (AU)
of the antimicrobial
activity of the sample
after its dialysis
Titration (AU) of the
antimicrobial activity
of the sample when its
initial ionic conditions
were restored
Titration (AU) of the
antimicrobial activity
of the dialyzed sample
after being stored
at 4 C for a week
SW 20% 1,280 1,280 1,280
H2O 640 640 0
SW 1% 640 640 0
SW 2% 640 640 0
SW 3% 640 1,280 160
SW 4% 640 1,280 320
SW 5% 1,280 1,280 1,280
SW 10% 1,280 1,280 1,280
SW 15% 1,280 1,280 1,280
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titration of the antimicrobial activity of the sample was
not aﬀected in solutions with ionic concentrations higher
than 5% (SW 5%). Dialysis of the supernatant against
lower salt concentrations produced an immediate de-
crease in its activity. This eﬀect was more evident when
the samples were stored at lower salt concentrations for
longer periods of time. These observations suggested
that halocin is inactivated at low ionic concentrations, as
has been observed for halocin H4, produced by a
diﬀerent strain of H. mediterranei. Activity could not be
restored by dialysis against the initial saline conditions
in samples that had lost their activity when dialyzed
against water and stored for 7 days. This observation
suggests that low ionic concentrations irreversibly inac-
tivate halocin H1.
Puriﬁcation of halocin H1
Due to the lack of stability of halocin H1 at low ionic
conditions, most of the classical techniques reported for
protein puriﬁcation would have failed to maintain its
inhibitory activity. Only a few procedures are available
for the puriﬁcation of halophilic proteins in the presence
of high ionic strength to maintain activity [5, 19].
The ﬁrst step of the puriﬁcation of halocin H1 was
carried out by aﬃnity chromatography using bacitracin
linked to Sepharose 4B. This step removes the extra-
cellular halophilic protease produced by H. mediterranei
[19] including strain Ma2. The usual methods for pro-
tease inactivation, (e.g. the addition of protease inhibi-
tors such as phenyl methyl sulfonyl ﬂuoride), could not
be used because Halobacterium salinarum NRC 817, the
test strain, was also sensitive to these agents (data not
shown).
Figure 1 shows the elution proﬁle of a concentrated
supernatant of 3.5 ml obtained from chromatography
on bacitracin-linked Sepharose 4B. The elution proﬁle
shows a protein peak that is retarded by the column and
which coincides with the maximum halocin inhibitory
activity. Sepharose 4B linked to bacitracin retarded the
elution of the halocin, probably due to hydrophobic
Fig. 1. Elution proﬁle of the
chromatography in Sepharose
4B linked to bacitracin of a
concentrate supernatant of
Haloferax mediterranei M2a.
Chromatographic conditions
are described in Materials and
methods
Fig. 2. Elution proﬁle of the
chromatography in hydroxyla-
patite of the active fractions
puriﬁed in the Sepharose col-
umn. m Protein concentration,
j antimicrobial activity against
Halobacterium salinarum NRC
817. The chromatographic con-
ditions are described in Mate-
rials and methods
17
interactions. This fact allows the recovery of a protein
fraction enriched in halocin activity.
While diﬀerent strategies were followed for the next
puriﬁcation step, the most successful result was obtained
by using chromatography on hydroxylapatite Biogel-
HTP column. This chromatographic system initially
retains proteins, which are released gradually by in-
creasing the ionic strength of the elution buﬀer. Figure 2
shows the elution proﬁle obtained for this column. Most
of the inhibitory activity was released when the sample
was eluted with 2 M NaCl, 10 mM potassium phosphate
buﬀer (pH 8). Fractions showing the highest antimi-
crobial activity were pooled and concentrated to 3.5 ml
as described in Materials and methods.
The degree of puriﬁcation obtained in the successive
steps was monitored by gel electrophoresis. Figure 3
shows that complete puriﬁcation is achieved after the
second chromatography step. The use of hydroxylapa-
tite as the only chromatographic system did not result in
the puriﬁcation of halocin H1 in a single step (data not
shown). The low recoveries obtained for the puriﬁcation
of halocin H1 (Table 2) could be explained by the gen-
eral tendency observed for halophilic proteins to be re-
tained in the membranes used. The molecular mass of
the protein that produces the inhibitory activity was
31 kDa by SDS-PAGE.
Antimicrobial spectrum
Another major feature in the characterization of a bac-
teriocin is its spectrum of activity. An important char-
acteristic of bacteriocins is that they inhibit
microorganisms closely related to the producer strain.
Halocin H1 does not inhibit the growth of halotol-
erant eubacteria (data not shown). Haloarchaeal strains
showed a diﬀerential degree of sensitivity (Table 3). This
result strongly suggests that the range of action of
halocin H1 is limited to haloarchaea. Halocin H1 was
very active against two of four species of the genus
Haloferax. The two strains of Halobacterium salinarum
tested could, in general, be considered sensitive, even
though major diﬀerences were found in their degree
of susceptibility. This could be due to the ability of
H. salinarum CCM 2090 to form aggregates during
growth, which make OD measurements diﬃcult. The
two species of the genus Haloarcula showed only
Fig. 3. SDS-PAGE of the pooled fractions obtained in the
diﬀerent puriﬁcation steps of halocin H1. Lanes: 1 and 5 Low-
molecular-weight calibration proteins (Pharmacia), 2 culture
supernatant, 3 pooled active concentrated fraction after chroma-
tography in Sepharose 4B-bacitracin, 4 pooled fraction containing
activity after hydroxylapatite chromatography
Table 2. Puriﬁcation of the halocin H1
Volume (ml) Total
protein (lg)
Activity Puriﬁcation
(fold)
Yield
(%)
Total (AU) Speciﬁc (AU/protein)
Supernatant 200 7 256,000 36 1 100
Concentrate 3.5 6.29 245,760 37.7 1 91
Sepharose 4B linked to bacitracin 3.5 0.5 81,920 146.2 4 32
Hidroxylapatite Bio-gel HTP 3.5 0.28 40,960 146.2 4 16
Table 3. Sensitivity of diﬀerent
haloarchaea to several concen-
trations of halocin H1,
measured in percentage of
inhibition with respect to non
treated controls
Inhibition (%)
64 UA/ml 32 UA/ml 16 UA/ml 8 UA/ml 4 UA/ml
Haloferax volcanii NCMB 2012 98 91 84 54 18
Haloferax gibbonsii ATCC 33959 100 100 75 50 9
Haloferax mediterranei M2a 0 0 0 0 0
Haloferax mediterranei ATCC 35500 0 0 0 0 0
Halobacterium salinarum CCM 2090 80 56 4 0 0
Halobacterium salinarum NRC 34002 100 100 97 83 51
Haloarcula hispanica ATCC 33960 59 42 30 20 10
Haloarcula vallismortis ATCC 24745 31 19 10 2 0
Halococcus morrhuae CCM 537 8 15 3 0 10
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moderate sensitivity, whereas a strain from the taxo-
nomically distant genus Halococcus was insensitive.
Other strains of H. mediterranei were found to be
resistant to halocin H1 using this test.
A cross-sensitivity assay was performed to check
whether there were antagonistic eﬀects between strains
of H. mediterranei. The results showed that the H1
producer, H. mediterraneiM2a, could inhibit the growth
of other strains, while being insensitive to the halocins
produced by the rest of the strains tested [17]. The only
cases in which this halocin failed to inhibit the growth of
other strains are M2b and M4, strains closely related to
the producing strain M2a [7] and thus which probably
produce the same halocin.
Discussion
The production of halocins is a common feature among
halobacteriaceae, although a recent study [6] questioned
the ecological, importance of these proteins in the
competition between diﬀerent halobacteria in hypersa-
line environments.
The aim of this work was to identify various prop-
erties of halocin H1 and compare them with the prop-
erties of halocins produced by other strains of the same
genus. Halocin H1 diﬀers from halocin H4 produced by
H. mediterranei ATCC 35500 in its molecular mass (31
vs 34.9 kDa) [2], and its producer strain can inhibit the
growth of H. mediterranei ATCC 35500, whereas the
opposite antagonism does not occur. Halocin H1 diﬀers
from halocin H6, among other characteristics, in its
sensitivity to low ionic strength.
Halocin H1 also shares some characteristics with
other proteinaceous ecological agents of prokaryotic
origin. For instance, this protein shows some degree of
taxonomic speciﬁcity, being more eﬀective against or-
ganisms classiﬁed within the same genus than the pro-
ducer strain, a feature observed in gram-negative
bacteria [3]. Also, other cultures of H. mediterranei
studied were inhibited by this bacteriocin, with the ex-
ception of the producer and related strains, suggesting
that these organisms have mechanisms of resistance to
the action of the halocin, as has been reported for some
bacteriocin-like proteins from gram-positive bacteria.
The mechanism of action of this bacteriocin is still un-
clear, although preliminary experiments have shown
that its eﬀects in H. salinarum NRC 817, are similar to
those observed for halocin H4.
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